We are live on ! Find out more
FOLD

Amicus Therapeutics

Delisted

FOLD was delisted on the 24th of April, 2026.

147 hedge funds and large institutions have $1.76B invested in Amicus Therapeutics in 2015 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 63 increasing their positions, 43 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

47% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 43

42% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 19

17% more funds holding in top 10

Funds holding in top 10: 67 (+1)

9% more capital invested

Capital invested by funds: $1.61B → $1.76B (+$150M)

5% more funds holding

Funds holding: 140147 (+7)

1% less call options, than puts

Call options by funds: $12.8M | Put options by funds: $12.9M

Holders
147
Holders Change
+7
Holders Change %
+5%
% of All Funds
4.1%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.2%
New
27
Increased
63
Reduced
43
Closed
19
Calls
$12.8M
Puts
$12.9M
Net Calls
-$167K
Net Calls Change
-$2.71M
Name Holding Trade Value Shares
Change
Change in
Stake
California Public Employees Retirement System
51
California Public Employees Retirement System
California
$4.4M
EI
52
EAM Investors
California
$4.34M -$3.2M -204,076 -40%
SFM
53
Sphera Funds Management
Israel
$4.34M -$2.2M -140,000 -31%
ACA
54
Apis Capital Advisors
New York
$4.15M -$885K -56,399 -16%
TCP
55
Tourbillon Capital Partners
New York
$3.5M +$3.92M +250,000 New
ACM
56
Asymmetry Capital Management
California
$3.26M +$3.65M +232,957 New
California State Teachers Retirement System (CalSTRS)
57
California State Teachers Retirement System (CalSTRS)
California
$2.96M +$554K +35,300 +20%
ACM
58
Atika Capital Management
New York
$2.9M +$359K +22,900 +12%
VOYA Investment Management
59
VOYA Investment Management
Georgia
$2.8M +$2.4M +153,100 +327%
QI
60
QS Investors
New York
$2.77M
TD Asset Management
61
TD Asset Management
Ontario, Canada
$2.46M +$59.6K +3,800 +2%
TA
62
Teachers Advisors
New York
$2.35M +$434K +27,694 +20%
GC
63
Guggenheim Capital
Illinois
$2.13M +$2.39M +152,635 New
CAM
64
Cormorant Asset Management
Massachusetts
$2.1M -$784K -50,000 -25%
BA
65
BlackRock Advisors
Delaware
$2.1M -$74.6K -4,758 -3%
HCMT
66
Highland Capital Management (Texas)
Texas
$1.96M -$2.84M -181,336 -56%
Group One Trading
67
Group One Trading
Illinois
$1.96M +$2.19M +139,913 New
Swiss National Bank
68
Swiss National Bank
Switzerland
$1.89M +$267K +17,000 +14%
Ameriprise
69
Ameriprise
Minnesota
$1.87M -$1.02M -65,130 -33%
GKIM
70
GW&K Investment Management
Massachusetts
$1.83M -$984K -62,745 -32%
MCM
71
Moore Capital Management
New York
$1.75M -$2.35M -150,000 -55%
New York State Common Retirement Fund
72
New York State Common Retirement Fund
New York
$1.58M +$796K +50,730 +81%
SGAM
73
Smith Group Asset Management
Texas
$1.48M -$514K -32,750 -24%
NFA
74
Nationwide Fund Advisors
Ohio
$1.45M +$192K +12,253 +13%
RhumbLine Advisers
75
RhumbLine Advisers
Massachusetts
$1.44M +$339K +21,613 +27%

FOLD Hedge Fund Activity: Q3 2015 in Review

147 of the 3,583 institutional investors tracked by Wall St. Rank reported a position in Amicus Therapeutics (FOLD) for Q3 2015, worth a combined $1.76B — up 9.4% from $1.61B a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new FOLD positions and 19 closed out — a net gain of 8 holders — while 63 added to existing stakes and 43 trimmed.

The largest buyer was Vanguard Group, adding an estimated $39.6M. The largest seller was Millennium Management, cutting an estimated $20.2M.

  • 147 institutional investors held Amicus Therapeutics (FOLD) as of Q3 2015, up from 140 in Q2 2015.
  • Funds reported $1.76B of Amicus Therapeutics stock for Q3 2015, up 9.4% quarter-over-quarter.
  • 27 funds opened new Amicus Therapeutics positions in Q3 2015 and 19 closed out, a net change of +8 holders.
  • The largest Amicus Therapeutics buyer in Q3 2015 was Vanguard Group, an estimated $39.6M added.
  • The largest Amicus Therapeutics seller in Q3 2015 was Millennium Management, an estimated $20.2M sold.

Based on aggregated 13F filings for Q3 2015.